These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35803214)

  • 1. Oncogenic transcription factors and neogenes: New opportunities for cancer immunotherapy?
    Abrash EW; Calabrese JM
    Mol Cell; 2022 Jul; 82(13):2353-2355. PubMed ID: 35803214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions.
    Vibert J; Saulnier O; Collin C; Petit F; Borgman KJE; Vigneau J; Gautier M; Zaidi S; Pierron G; Watson S; Gruel N; Hénon C; Postel-Vinay S; Deloger M; Raynal V; Baulande S; Laud-Duval K; Hill V; Grossetête S; Dingli F; Loew D; Torrejon J; Ayrault O; Orth MF; Grünewald TGP; Surdez D; Coulon A; Waterfall JJ; Delattre O
    Mol Cell; 2022 Jul; 82(13):2458-2471.e9. PubMed ID: 35550257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human transcription factor and protein kinase gene fusions in human cancer.
    Salokas K; Weldatsadik RG; Varjosalo M
    Sci Rep; 2020 Aug; 10(1):14169. PubMed ID: 32843691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of an oncogenic fusion protein by a viral gene--a new chapter in an old story.
    Kirn D; Hermiston T
    Nat Med; 1999 Sep; 5(9):991-2. PubMed ID: 10470071
    [No Abstract]   [Full Text] [Related]  

  • 5. Developmental origins and emerging therapeutic opportunities for childhood cancer.
    Filbin M; Monje M
    Nat Med; 2019 Mar; 25(3):367-376. PubMed ID: 30842674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.
    Vegi NM; Klappacher J; Oswald F; Mulaw MA; Mandoli A; Thiel VN; Bamezai S; Feder K; Martens JHA; Rawat VPS; Mandal T; Quintanilla-Martinez L; Spiekermann K; Hiddemann W; Döhner K; Döhner H; Stunnenberg HG; Feuring-Buske M; Buske C
    Cell Rep; 2016 Jul; 16(2):498-507. PubMed ID: 27346355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
    Basili T; Dopeso H; Kim SH; Ferrando L; Pareja F; Da Cruz Paula A; da Silva EM; Stylianou A; Maroldi A; Marchiò C; Rubin BP; Papotti M; Weigelt B; Moreira Ferreira CG; Lapa E Silva JR; Reis-Filho JS
    Int J Cancer; 2020 Oct; 147(8):2253-2264. PubMed ID: 32383186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment.
    Willis RE
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene fusions in tumourigenesis with particular reference to ovarian cancer.
    Zhou Y; El-Bahrawy M
    J Med Genet; 2021 Dec; 58(12):789-795. PubMed ID: 34462289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.
    French CA; Rahman S; Walsh EM; Kühnle S; Grayson AR; Lemieux ME; Grunfeld N; Rubin BP; Antonescu CR; Zhang S; Venkatramani R; Dal Cin P; Howley PM
    Cancer Discov; 2014 Aug; 4(8):928-41. PubMed ID: 24875858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the Molecular Signature of Salivary Gland Neoplasms with Tumor-specific Fusion Oncogenes.
    Patil S; Rao R; Raj T
    J Contemp Dent Pract; 2015 May; 16(5):i-ii. PubMed ID: 26162265
    [No Abstract]   [Full Text] [Related]  

  • 12. Report of the International Meeting on Chromosome 12 Genes in Cancer.
    Van de Ven W; Hagemeijer A; Kucherlapati R; Marynen P
    Cytogenet Cell Genet; 1996; 73(1-2):25-32. PubMed ID: 8646887
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncogenic fusion proteins and their role in three-dimensional chromatin structure, phase separation, and cancer.
    Quiroga IY; Ahn JH; Wang GG; Phanstiel D
    Curr Opin Genet Dev; 2022 Jun; 74():101901. PubMed ID: 35427897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
    French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
    Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MiTF/TFE Family of Transcription Factors: Master Regulators of Organelle Signaling, Metabolism, and Stress Adaptation.
    Slade L; Pulinilkunnil T
    Mol Cancer Res; 2017 Dec; 15(12):1637-1643. PubMed ID: 28851811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal translocations in human cancer.
    Rabbitts TH
    Nature; 1994 Nov; 372(6502):143-9. PubMed ID: 7969446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
    Linn DE; Bronson RT; Li Z
    PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways.
    Seliger B; Massa C
    Front Immunol; 2022; 13():883639. PubMed ID: 35663987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights.
    Ladanyi M
    Cancer Biol Ther; 2002; 1(4):330-6. PubMed ID: 12432241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer.
    Yang K; Li C; Liu Y; Gu X; Jiang L; Shi L
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.